News tagged with clopidogrel

Related topics: patients , heart attack , thrombosis , aspirin , blood clots

Anti-clotting drugs yield similar results

The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs – prasugrel and clopidogrel – in preventing ...

Aug 26, 2012
popularity not rated yet | comments 0 | with audio podcast

World's first bedside genetic test proves effective

Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) ...

Nov 09, 2011
popularity not rated yet | comments 0 | with audio podcast

Clopidogrel

Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. It is marketed by Bristol-Myers Squibb and Sanofi-Aventis under the trade name Plavix. The drug works by irreversibly inhibiting a receptor called P2Y12, an adenosine diphosphate ADP chemoreceptor. Adverse effects include hemorrhage, severe neutropenia, and thrombotic thrombocytopenic purpura (TTP).

This text uses material from Wikipedia licensed under CC BY-SA